About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

TSUMURA & CO.(4540) Summary

4540
TSE Prime
TSUMURA & CO.
3,987
JPY
-70
(-1.73%)
Apr 9, 3:30 pm JST
27.42
USD
Apr 9, 2:30 am EDT
Result
PTS
outside of trading hours
3,916.8
Apr 9, 8:48 pm JST
Summary Chart Historical News Financial Result
PER
8.8
PBR
1.03
Yield
3.41%
Margin Trading Ratio
6.74
Stock Price
Apr 9, 2025
Opening Apr 9, 9:00 am
4,000 JPY 27.42 USD
Previous Close Apr 8
4,057 JPY 27.50 USD
High Apr 9, 11:26 am
4,014 JPY 27.55 USD
Low Apr 9, 9:08 am
3,935 JPY 27.00 USD
Volume
299,300
Trading Value
1.19B JPY 8.18M USD
VWAP
3974.51 JPY 27.34 USD
Minimum Trading Value
398,700 JPY 2,742 USD
Market Cap
0.31T JPY 2.11B USD
Number of Trades
1,243
Liquidity & Number of Trades
As of Apr 9, 2025
Liquidity
High
1-Year Average
1,309
1-Year High May 13, 2024
6,751
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 4, 2025 6,800 914,800 134.53
Mar 28, 2025 9,500 1,056,100 111.17
Mar 21, 2025 14,800 1,071,800 72.42
Mar 14, 2025 15,900 1,062,600 66.83
Mar 7, 2025 1,097,300 923,800 0.84
Company Profile
TSUMURA & CO. is the leading company specializing in Kampo medicines, expanding its focus on medications for the elderly, cancer patients, and women's health. The company is also developing its business in China.
Sector
Pharmaceuticals
TSUMURA & CO. primarily engages in the manufacture and sale of Kampo medicines, offering both prescription and over-the-counter pharmaceuticals. The company has established an integrated production system from the cultivation of raw medicinal herbs to product manufacturing, ensuring thorough quality control. In Japan, TSUMURA & CO. has secured its position as the undisputed top manufacturer of prescription Kampo preparations. In recent years, the company has been actively expanding into the Chinese market, strengthening its local production and sales capabilities through capital and business alliances with local enterprises. Furthermore, TSUMURA & CO. is advancing its global business operations, including drug development in the United States and cultivation of raw medicinal herbs in Laos. The company focuses on promoting Kampo medicine and developing evidence-based Kampo preparations to address the diversifying needs in healthcare.